Chilivis Grubman LLP
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Joseph J. Siegelman
    • Hakim Hilliard
    • Sanjay Karnik
    • Brandi Z. Murrain
    • Rachel N. Lugay
    • Maiysha Rashad
  • Practice Areas
    • Healthcare
      • Government Investigations & Litigation
      • Payor Audits and Audit Appeals
      • HIPAA and Cybersecurity
      • Medical Board Investigations
      • Peer Review & Credentialing Disputes
      • Healthcare Regulatory Compliance
    • Civil and Business Litigation
      • Class Action Defense
    • Criminal Defense
      • White Collar Crime
      • Healthcare Fraud
      • Public Corruption
      • Internal Investigations
    • False Claims Act and Qui Tam Defense
    • Data Privacy & Cybersecurity
    • Internal Investigations
    • Government Affairs
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
      • Advertising Compliance
      • Land Use & Zoning
      • Licensing and Permits
    • Campaign Finance and Election Law
    • Entertainment Law & Artist Management
      • Trademark, Copyright, and Brand Protection
  • Blog
  • News
  • Insights
  • Contact
Select Page

State False Claims Acts and Their Role in Fraud Enforcement

Aug 18, 2025 | False Claims Act, Fraud Investigations, Health Care, Health Care Fraud

We write frequently about the federal False Claims Act (FCA), which is the federal government’s most powerful civil fraud fighting tool. Healthcare providers, government contractors, and any other business that submits claims for reimbursement to the federal...

False Claims Act Risks for Healthcare Private Equity Investors

Aug 14, 2025 | False Claims Act, federal investigations, Health Care, Health Care Fraud, Healthcare Transactions

The federal False Claims Act (FCA) represents one of – if not the – top regulatory and liability risk that healthcare providers face when doing business with federal healthcare programs (FHPs) including Medicare and Medicaid. The FCA prohibits, among other things,...

Leading Medical Organizations Excluded from CDC’s Advisory Committee on Immunization Practices

Aug 11, 2025 | Health Care

Federal health leaders have excluded major medical organizations including the American Medical Association (AMA), the American Academy of Pediatrics (AAP), the American College of Physicians (ACP), and the Infectious Diseases Society of America (IDSA), from...

33-Year-Old Man Faces up to 20 years in Prison for Hospice Fraud

Jul 21, 2025 | Health Care

The DOJ announced that Juan Carlos Esparza, a 33-year-old resident of Valley Village, California, has pleaded guilty to defrauding Medicare of approximately $16 million by operating a network of fraudulent hospice companies. Esparza and his co-conspirators ran at...

DOJ and State Medicaid Units Announce Massive Judgments Against Lab and Owners

Jul 17, 2025 | False Claims Act, Fraud Investigations, Government Investigations, Health Care, Health Care Fraud, Medicare and Medicaid

On July 17, 2025, the Department of Justice (DOJ) and the States of Colorado, Georgia, and South Carolina announced that the former CEO and owner of a now-defunct laboratory agreed to a consent judgment of over $27.5 million under the False Claims Act (FCA),...

Can Breaching a Contract With the Government Result in False Claims Act Liability? It Depends…

Jul 17, 2025 | False Claims Act, federal investigations, Government Investigations, Health Care, Health Care Fraud

The False Claims Act (FCA) is the government’s most powerful civil tool to investigate and pursue claims against businesses and individuals who submit false or fraudulent claims to the government. Every year, the Department of Justice (DOJ) obtains billions of dollars...
« Older Entries

Recent Posts

  • Florida Attorney General Files False Claims Act Lawsuit Against Textbook Publishers
  • State False Claims Acts and Their Role in Fraud Enforcement
  • Serial FCA Relator Scores Yet Another Massive PPP Loan Settlement
  • False Claims Act Risks for Healthcare Private Equity Investors
  • Land Use Win for Little Five Points: Findley Plaza Redesign Breaks Ground

Categories

  • A.I. Law
  • Accessory Dwelling Units
  • Administrative Law
  • Anti-Counterfeit
  • Atlanta News
  • Brand Protection
  • Business Litigation
  • Civil Healthcare Litigation
  • Civil Matters
  • Civil Rights
  • Code Enforcement
  • Commercial Litigation
  • Commercial Payor Audits
  • Complex Criminal Litigation
  • Copyright Infringement
  • COVID-19 Related Law
  • Criminal Matters
  • Cyber Law
  • Data Breach
  • DMEPOS
  • DOJ
  • Drug Policy Law
  • Election Law
  • Employment Law
  • Environmental
  • False Claims Act
  • federal investigations
  • Federal Tax Investigations
  • FINRA
  • Firm Announcement
  • FOIS Compliance
  • Fraud Investigations
  • General
  • Government Affairs
  • Government Contract
  • Government Investigations
  • Government Litigation
  • Health Care
  • Health Care Fraud
  • Healthcare Transactions
  • HIPAA
  • Housing Development Law
  • Land Use Law
  • Land Zoning Law
  • Liquor Law
  • Medicare and Medicaid
  • Non-Profit Organizations
  • ommercial payor audits
  • Open Records Act
  • Overpayment Appeals
  • PPP Investigations
  • Public Corruption
  • Restrictive Covenants
  • SEC Investigations
  • Special Use Permit Filing
  • State Bar of Georgia Investigations
  • Strategic Land Use
  • Tax Fraud
  • toxic tort
  • Trademark Enforcement
  • Trademark Protection
  • Tree Ordinance
  • Uncategorized
  • Variances
  • White Collar Crime
  • Zoning and Land Use
Built by The Montgomery Group